Company Overview: Nufarm Limited (ASX: NUF) is an Australasian marketer and manufacturer of chemicals. It is also engaged in the manufacture and sale of crop protection products and its proprietary seed technologies business. The business of NUF has two reporting segments, namely Seed Technologies and Crop Protection. Seed technologies combine the seed treatment portfolio and the Nuseed business whereas Crop Protection develops, manufacture, and sell crop protection solutions including herbicides, insecticides and fungicides that help growers protect crops against weeds, pests, and disease.
NUF Details
Cost-Competitive Business Model and Decent Increase in Revenues: Nufarm Limited (ASX: NUF) is an Australasian marketer and manufacturer of chemicals. It is also engaged in the manufacturing and sale of crop protection products and its proprietary seed technologies. As on 18 August 2020, the market capitalization of the company stood at ~$1.64 billion. 2019 has been a year of significant progress and change for Nufarm Limited. During the year, the company progressed the integration of the European portfolios and made significant progress in bringing a large, new value stream with omega 3 canola. During FY19, the company focused on strengthening its business to improve returns. The company aims to build a cost-competitive business model and is focused on improving the quality of earnings to create a strong platform to support continued profitable growth.
NUF has a large scale and global distribution footprint, making it an attractive partner for major manufacturers and research organizations. During FY19, group revenues went up by 14% to $3.76 billion, up from $3.31 billion in FY18. The increase in revenues, however, was partially offset by the impact of increased competition, cost pressures and pricing pressure resulting in a decline in gross profit margin to 27.5% from 29.1% in the prior year. In the same time span, underlying EBITDA of the company increased by 9% to $420 million, mainly due to the contribution from the European portfolios and decent earnings in North America, Seed Technologies, and Asia. However, continued drought in Australia, supply disruptions in the European business, and extensive flooding in North America impacted earnings for FY19. The company managed to respond to the external challenges and strengthened its business with the equity raising and a deleveraging program to further reduce debt.
NUF has made significant investments during the year and is likely to benefit from increased earnings along with continued improvement in its Australian business. The company is maintaining its gross margin and is working on improving its product quality.
The company has invested in future growth and is working on improving its global competitiveness by broadening its European portfolios and strengthening its pipeline of new products. NUF is confident about the quality of the investments and is focused on generating stronger cash returns.
FY19 Financial Highlights (Source: Company Reports)
Details of Top 10 Shareholders: The following table provides an overview of the top 10 shareholders of Nufarm Limited. Sumitomo Chemical Co Ltd is the largest shareholder in the company, with a percentage holding of 15.87%.
Top 10 Shareholders (Source: Refinitiv, Thomson Reuters)
Key Margins: During 1H20, gross margin of the company stood at 26.9%, reflecting a slight decline over the previous half. In the same time span, current ratio of the company stood at 1.76x, higher than the industry median of 1.43x. This indicates that the company is liquid enough to pay off its current liabilities using its current assets. During the half-year, debt/equity ratio of the company was 1.05x, and assets/equity ratio of the company stood at 3.21x.
Key Margins (Source: Refinitiv, Thomson Reuters)
Completion of Sale of South American Businesses: The company has completed the sale of its South American crop protection and seed treatment operations in Brazil, Argentina, Colombia and Chile to Sumitomo Chemical Company Limited. This sale is likely to strengthen the balance sheet of the company and will enable the firm to focus on improving cash generation across its businesses.
Half-Year Results: During 1H20, revenue of the company went down by 6% to $1,477 million, and underlying EBITDA of the company stood at $66 million. In the same time span, free cash flow of the company improved by $170 million and the company strengthened its balance sheet following the sale of South American businesses. During the half-year, the company made decent progress against its priorities and experienced increasing demand with the improvement in weather conditions. With the increased earnings from European, Nuseed and North American businesses, the company may distribute increasing returns for shareholders in the coming years. The company continued to simplify its business, optimized its cost base, and continued to progress on its key initiatives to lift its performance.
During the third quarter of FY20, the company saw solid demand for new seed varieties and witnessed an increase in revenues, gross profit, and underlying EBITDA. Despite the impact of difficult weather conditions in key markets and weaker demand due to COVID-19, the company seems to be well positioned to navigate the current uncertainty with a stronger balance sheet and liquidity position. The company retains an attractive scaled platform with an established, global footprint and capability and retains a significant pipeline of opportunities.
1H20 Financial Highlights (Source: Company Reports)
Canadian Regulatory Approvals for Omega-3 Canola: The company has received approvals from the Canadian regulatory authorities for its proprietary Nuseed Omega-3 Canola relating to cultivation, use in aquafeed and livestock feed, and for human consumption. The Canadian Food Inspection Agency confirmed that Nuseed Omega-3 Canola does not possess any environmental risk as compared to other cultivated canola, and hence, is approved for cultivation.
Key Risks: The company is exposed to a variety of risks including the political ambition to reduce the overall use and risk of chemical pesticides, the risks and uncertainties associated with the ongoing impacts of COVID-19 and the global economic environment, climate and seasonality, volatility in commodity prices, foreign exchange risks, risks from grower options and technology, debt financing risk, IP rights and branded names, relationships with channel partners and commercial counterparties, etc.
Future Expectations and Outlook: The company is focused on reducing its cost base and continues to be disciplined in managing working capital. The company is further looking to benefit from upcoming opportunities to reduce costs. NUF seems to be well-positioned to meet increased demand supported by its local manufacturing footprint. The company is also working to strengthen its supply chain processes. It is also dedicated to develop a seeds platform and commercializing omega 3 and is likely to witness positive momentum to pursue the portfolio acquisitions.
Despite resilience during the initial phases of the COVID-19 pandemic, the pandemic may create uncertainties and challenges. With this uncertainty, the customers are not willing to purchase products, and the significant volatility may impact NUF’s financing costs for the second half of the financial year. The company is likely to release its FY20 results on 23 September 2020. The company has decided to change its financial year from 31 July 2020 to 30 September 2020 to align its half year reporting period with its sales period.
Key Valuation Metrics (Source: Refinitiv, Thomson Reuters)
Valuation Methodology: P/E Multiple Based Relative Valuation (Illustrative)
P/E Multiple Based Relative Valuation (Source: Refinitiv, Thomson Reuters)
Note: All the forecasted figures are taken from Thomson Reuters, NTM: Next Twelve Months
Stock Recommendation: The company continued to deliver on its strategy and focused on meeting the expectations of its shareholders. NUF retains a decent balance sheet and ample liquidity to navigate these unprecedented circumstances posed by the global pandemic. As per ASX, the stock of NUF gave a return of 7.75% in the past one month and is inclined towards its 52-weeks’ low level of $3.710, proffering a decent opportunity for accumulation. The company may witness near term uncertainty but seems to be well-capitalized to benefit in the longer term. We have valued the stock using the P/E multiple based illustrative relative valuation and have arrived at a target price of low double-digit growth (in percentage terms). Considering the current trading levels, decent returns in the past one month, modest long-term outlook and resilience in the softer market conditions, we recommend a ‘Buy’ rating on the stock at the current market price of $4.300, down by 0.232% on 18 August 2020.
NUF Daily Technical Chart (Source: Refinitiv, Thomson Reuters)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as personalised advice.